venetoclax,nelarabine,bortezomib,Rituximab,Imatinib,Idarubicin
abbvie,takeda,roche,pfizer,Novartis
['elara', 'venetoclax', 'bortezomib', 'nelarabine', 'borte']
gmall 2013 trial in t- all: pediatric inspired up to age 55, intensive use of , asp, reinduction ,early transplant in etcp abstract 51 #ash22 